Back to articles
Comparative guide · 6 min read

Methylcobalamin vs Cyanocobalamin — which B12 form is actually better?

Updated 2026-05-14 · Reviewed by SupplementScore editors · No sponsorships

For routine B12 supplementation in otherwise healthy adults, the two forms produce indistinguishable clinical outcomes at equivalent doses — cyanocobalamin is cheaper and equally effective. The case for methylcobalamin is narrower: specific neurological indications, heavy smokers (theoretical), and severe renal impairment.

Quick verdict

GoalBetter choiceWhy
Routine B12 repletion in healthy adultsCyanocobalaminEqually effective at correcting low B12, more stable, cheaper. The form used in nearly all studies.
Vegan B12 maintenanceEither worksBoth correct vegan-pattern deficiency. Tissue retention may favor methylcobalamin marginally; cost favors cyanocobalamin.
Diabetic peripheral neuropathyMethylcobalaminHigh-dose methylcobalamin (1,500 mcg/day) has trial evidence for symptomatic improvement; cyanocobalamin trials are weaker for this indication.
Heavy smokers (cyanide load)Methylcobalamin (mild edge, theoretical)Cyanocobalamin contributes a tiny cyanide moiety on conversion; clinically irrelevant in most people but a theoretical concern in heavy smokers and Leber's hereditary optic neuropathy.
Severe renal impairmentMethylcobalaminAvoid cyanocobalamin in advanced kidney disease — the cyanide moiety is renally cleared and can accumulate.
Cost per doseCyanocobalaminAbout 3–5× cheaper than methylcobalamin at equivalent doses.

How they actually work

Cyanocobalamin — the supplement-industry standard

Cyanocobalamin is a synthetic form not found in nature, generated by adding a cyanide group to the cobalamin molecule during manufacturing. The body removes the cyanide group and converts cyanocobalamin to the two biologically active forms — methylcobalamin (cytoplasmic) and adenosylcobalamin (mitochondrial). The cyanide load from a typical 1,000 mcg dose is about 20 mcg — small enough to be cleared without concern in normal renal function and well below daily background cyanide exposure from foods and smoking.

Methylcobalamin — the active circulating form

Methylcobalamin is one of the two coenzyme-active forms of B12 in human tissues. By supplying the molecule directly, you bypass the cellular conversion of cyanocobalamin. The theoretical case is faster availability and avoiding the cyanide moiety; the empirical case in healthy adults is modest because the conversion step is not rate-limiting at typical supplement doses.

Bioavailability and retention

Oral absorption is similar between forms — both depend on intrinsic factor at physiologic doses and on passive diffusion at high doses (which is why 500–1,000 mcg oral doses work even in pernicious anemia, despite the absence of intrinsic factor). Urinary excretion is higher with cyanocobalamin in the first 24 hours, suggesting slightly better tissue retention with methylcobalamin and hydroxocobalamin. Whether this matters clinically at maintenance doses is unclear; both forms correct serum B12, MMA, and homocysteine.

Neurological indications — where methylcobalamin earns its premium

The strongest case for methylcobalamin is diabetic peripheral neuropathy, where high-dose methylcobalamin (1,500 mcg/day) has trial evidence for improvement in nerve conduction parameters and symptomatic scores. The mechanism likely involves direct supply for myelin repair and homocysteine remethylation in nerve tissue. Cyanocobalamin trials for the same indication exist but with weaker results. For confirmed B12-deficiency neuropathy, either form will resolve the deficiency, but methylcobalamin is the form with the more impressive symptomatic-improvement trial data.

The Leber's edge case

Leber's hereditary optic neuropathy (LHON) is a mitochondrial disorder where cyanide handling is impaired. Cyanocobalamin is conventionally avoided in known LHON or known suspected carriers. This is a rare-disease consideration that gets overgeneralised in supplement marketing — for the general population, the cyanide moiety in cyanocobalamin is clinically irrelevant.

Hydroxocobalamin — the third form often ignored

Hydroxocobalamin is the form used in IM injections for severe deficiency; it has the longest tissue retention of any B12 form and the highest single-dose bioavailability. It's not typically available over the counter in oral form in the US. If you've been prescribed B12 injections, those are usually hydroxocobalamin or cyanocobalamin.

Practical rule. Generic adult B12 supplementation: cyanocobalamin 250–1,000 mcg/day — cheap, stable, effective. Vegan maintenance: either form at 250 mcg/day or 1,000 mcg twice a week. Diabetic peripheral neuropathy: methylcobalamin 1,500 mcg/day (with prescriber). Advanced kidney disease, LHON, or heavy smokers wanting belt-and-braces caution: methylcobalamin. Skip the influencer claim that methylcobalamin is dramatically better for everyone — that isn't what the comparative trial data show at typical doses.

Dose, form, and timing

Cyanocobalamin: 250–1,000 mcg/day oral, or 1,000 mcg twice weekly. Sublingual tablets are not pharmacokinetically superior to swallowed tablets at the same dose despite marketing claims.

Methylcobalamin: 500–1,000 mcg/day for maintenance; 1,500 mcg/day in the diabetic peripheral neuropathy protocol. Sublingual versions exist; same caveat as above.

Safety

B12 is water-soluble and has no defined upper limit. Toxicity is essentially unheard of from oral supplementation. The main practical safety issue is that high-dose folate alongside undiagnosed B12 deficiency can produce hematologic correction (normal CBC) while neurologic damage progresses — check B12 status before starting high-dose folic acid or methylfolate, particularly in older adults.

What we'd actually buy

For most adults including vegans: cyanocobalamin 1,000 mcg/day or 1,000 mcg twice weekly — cheap, effective, well-tolerated. For users with diabetic peripheral neuropathy under prescriber care, or with confirmed pernicious anemia: methylcobalamin 1,500 mcg/day or whichever form your prescriber recommends. Save the methylcobalamin premium for the conditions where it earns it.

Sources

Read more: